Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-17

Clinical Trial Update: Zolpidem (Myslee) Post Marketing Study in Adolescent Patients With Insomnia - Evaluation With Polysomnography [Phase 4]

View source ↗

Summary

Phase 4 post-marketing study evaluating zolpidem Myslee in adolescents with insomnia, assessed by polysomnography (study completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Myslee (zolpidem)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Insomnia, Sleep Initiation and Maintenance Disorders | Phase 4 | Status: COMPLETED